[1]
Savvidou Α., “Real-World Data on the Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced/Metastatic Breast Cancer”, World J Oncol, vol. 17, no. 3, pp. 380–393, Jan. 2026, doi: 10.14740/wjon2750.